Abstract: An image sensor having photosites forming an array (K×L) of K rows and L columns, including a first set of integrator circuits, with a first regulation by analog weighting in blocks of n×n? photosites, said photosites belonging to n adjacent columns and to n? adjacent rows, and a second set of integrator circuits, with a second regulation by analog weighting in blocks of m×m? photosites, said photosites belonging to m adjacent columns and to m? adjacent rows, n adjacent columns of a first set of columns of the array being connected to n×n? integrator circuits of the first set, m adjacent columns of a second set of columns of the array being connected to m×m? integrator circuits of the second set, n columns of the first set alternating with m columns of the second set to form the array of photosites.

Abstract: The invention relates to a method of testing an infant, comprising the following steps: displaying a target on a screen; detecting contact made by the infant with the screen inside and/or outside the target; calculating a success parameter on the basis of the contact detected; and recording the calculated success parameter in a memory.

Abstract: The present invention relates to a solar surface receptor module that operates at a high temperature and comprises a channel (101) extending therethrough and along which a heat transfer occurs between a fluid (liquid or gas) moving in said channel (101) and at least one wall (104) of the receptor exposed to concentrated solar radiation, characterized in that the inner surface (105) of at least said wall includes turbulence-generating actuators (110) at the fluid inlet (102). The present invention also relates to a solar receptor therefor.

Abstract: The invention concerns compositions that can be cured in the presence of water or atmospheric moisture comprising at least one polyorganosiloxane having one or a plurality of condensable group(s) or hydrolysable and condensable group(s) and at least one compound capable of catalyzing the condensation reaction of the condensable or hydrolysable and condensable groups of the polyorganosiloxane. This compound is a heterometallic complex of which the chemical formula comprises at least two different metal atoms M and M?, M being an atom chosen from the group consisting of the atoms of columns 2 and 13 of the periodic table and M? being an atom chose from the group consisting of the atoms of column 4 of the periodic table, and at least one alkoxide or chelating ligand.

Abstract: Methods for preventing or treating retroviral infection not HIV and/or for preventing, inhibiting or treating a disease caused by the retroviral infection include contacting a cell with compound (I) wherein: means a pyridazine, pyrimidine or pyrazine group, R independently represent a hydrogen atom, halogen atom or group chosen among a —CN, hydroxyl, —COOR1, (C1-C3)fluoroalkyl, (C1-C3)fluoroalkoxy, —NO2, —NR1R2, (C1-C4)alkoxy, phenoxy and (C1-C3)alkyl group, the alkyl being optionally mono-substituted by hydroxyl group, n is 1, 2 or 3, n? is 1 or 2, R? is a hydrogen atom, halogen atom or group chosen among (C1-C3)alkyl group, hydroxyl group, —COOR1 group, —NO2 group, —NR1R2 group, morpholinyl or morpholino group, N-methylpiperazinyl group, (C1-C3)fluoroalkyl group, (C1-C4)alkoxy group and —CN group, Z is N or C, Y is N or C, X is N or C, W is N or C, T is N or C, U is N or C.

Abstract: A system and method are provided which employ a neural network model which has been trained to predict a sequentialized form for an input text sequence. The sequentialized form includes a sequence of symbols. The neural network model includes an encoder which generates a representation of the input text sequence based on a representation of n-grams in the text sequence and a decoder which sequentially predicts a next symbol of the sequentialized form based on the representation and a predicted prefix of the sequentialized form. Given an input text sequence, a sequentialized form is predicted with the trained neural network model. The sequentialized form is converted to a structured form and information based on the structured form is output.

Abstract: The disclosure relates to the fabrication of a three dimensional [3-D] cell culture membrane comprising one or more functionalized surfaces adapted to provide cell culture conditions suitable for the analysis of proliferation, differentiation or function of cells, typically eukaryotic or prokaryotic cells.

Abstract: The invention concerns a composition made from at least one sulphated polysaccharide, in particular from an algae, and combined with at least one food ingredient. This composition can be used, in particular, in the field of food or in the treatment or prevention of an infection caused by microsporidia in humans or animals. It has useful properties as an antiparasitic agent in humans or animals; for the treatment or prevention of an infection caused by at least one microsporidia in humans or animals; in particular for the treatment or prevention of an infection caused in bees by the microsporidia Nosema, preferably Nosema ceranae or Nosema apis, or indeed for stimulating the immune defences of bees.

Abstract: A method for 3D printing, wherein elementary volumes, or voxels, of a material are sequentially transformed by irradiation, including the following steps: breaking down, into identical blocks, the volume of part of an object to be printed that does not require a maximum resolution; for printing, associating with each block a brick having the same contour and comprising hollow portions; and irradiating in order to print the voxels of the bricks.

Abstract: An electronic power device including: a first electronic power component in which all the electrodes are arranged at a first main face of the first electronic power component; and an electric contact element in which a first main face is arranged against the first main face of the first electronic power component and which includes plural separate electrically conductive portions to which the electrodes of the first electronic power component are electrically connected. The first electronic power component and the electric contact element together form a stack such that a first lateral face of each of the portions of the electric contact element, substantially perpendicular to the first main face of the electric contact element, is arranged against at least one metallization of a support forming an electric contact of the first electronic power component.

Abstract: The present invention relates to activated neurotensin, pharmaceutical compositions comprising the same, and the uses thereof. The compounds and compositions of the invention may be used, e.g., to reduce body temperature, attenuate or halt seizures, reduce excitotoxicity, promote neuroprotection, reduce neuroinflammation and aberrant axonal sprouting or reduce pain.

Abstract: The present invention relates to the field of medicine. It relates more particularly to the use of compounds to prevent and/or treat lipotoxicity in a subject, especially lipotoxicity by hypoxia. The invention relates more particularly to compositions, especially pharmaceuticals compositions and nutritional supplements or complements comprising such compounds as well as their use to prevent and/or treat lipotoxicity, especially lipotoxicity by hypoxia. The compounds and compositions of the invention can especially be advantageously used to prevent and/or treat a pathology from among pulmonary pathologies, especially cystic fibrosis or a chronic obstructive pulmonary disease.

Abstract: The present invention is directed to an entity comprising a particle attached to at least one polymer M through one or several supramolecular interactions -A-B- constituted by 2 to 8 hydrogen bonds X-H-Y, wherein A and B are functional groups respectively grafted to P and M thus forming the particle-containing entity P-(A-B-M)x with x being greater than or equal to 1, functional group(s) B being positioned at one end of the polymeric chain of polymer M, X and Y are heteroatoms present in A and B functional groups, H is hydrogen, and M has a degree of polymerization comprised between 5 and 1000, preferably ranging from 5 to 500. The invention is also directed to a method for preparing this particle-containing entity P-(A-B-M)x, a method for sequentially forming and breaking the supramolecular interactions -A-B- in said particle-containing entity P-(A-B-M)x and dispersions comprising the same.

Abstract: A process for preparing a carboxylic acid, including a step of bringing at least one vicinal diol or at least one vicinal polyol into contact with an atmosphere including oxygen, and a catalyst, and in the absence of additional solvent.

Abstract: Some embodiments are directed to a method for manufacturing photonic waveguides and to photonic waveguides manufactured by this method.

Abstract: The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to the use of a panicein or a derivative thereof, to decrease or inhibit, in vitro or ex vivo, the Patched receptor drug efflux activity, in particular the chemotherapeutic drug efflux activity and chemotherapy resistance. The present disclosure further relates to uses of such compounds, in particular to prepare a pharmaceutical composition to allow or improve the efficiency of a therapy of cancer in a subject in need thereof. The compound of the invention can indeed be advantageously used, in combination with at least one chemotherapeutic drug, for treating cancer, for preventing cancer metastasis and/or for preventing cancer recurrence in a subject.

Abstract: The present invention relates to piperazine phenothiazine derivatives useful as therapeutic agents for treating spasticity, particularly following an ischemia or traumatic injury, or compression syndrome. The invention further relates to a pharmaceutical composition comprising a compound of the invention for treating spasticity.

Abstract: A microelectromechanical device comprising a mechanical structure extending along a longitudinal direction, linked to a planar substrate by an anchorage situated at one of its ends and able to flex in a plane parallel to the substrate, the mechanical structure comprises a joining portion, which links it to each anchorage and includes a resistive region exhibiting a first and second zone for injecting an electric current to form a resistive transducer, the resistive region extending in the longitudinal direction from an anchorage and arranged so a flexion of the mechanical structure in the plane parallel to the substrate induces a non-zero average strain in the resistive region and vice versa; wherein: the first injection zone is carried by the anchorage; and the second injection zone is carried by a conducting element not fixed to the substrate and extending in a direction, termed lateral, substantially perpendicular to the longitudinal direction.

Abstract: An acoustically absorbent cell for an acoustic panel, comprising a layer with a porous matrix incorporating a plurality of acoustic resonators between a first face and a second face of the porous matrix is described. The resonators are ordered so as to form at least two substantially parallel rows each comprising at least two resonators and extending along the first and second faces.

Abstract: A method for a real-time dynamic simulation of a response of a complex system or process controlled by a plurality of driving factors Pi (i=1 . . . k), each varying in a given range of variation. The range of variation of the driving factor Pi is discretized into NPi values. A prior parametric model of simulation is obtained in the form of a functional equation connecting the response to variations in the plurality of driving factors for any combination of values of the driving factors. Their range of variation is in the form of a sum of N modes that are functions of the factors. Each mode is defined for each of the NPi discretized values. The parametric model is stored in the form of a computer program in an independent device comprising a processor capable of running the program.